Montélimar

Breast Cancer Research

Innovative clinical trials focusing on hormone-positive breast cancer patients at high risk of relapse. The research explores the effectiveness of combining everolimus with standard endocrine therapy for improved disease-free survival.

Hormone Receptor Positive (ER+) Cancer
HER2-Negative Breast Cancer
Adjuvant Therapy

This research aims to enhance treatment outcomes for breast cancer survivors through targeted therapeutic approaches.

Colorectal Oncology

Groundbreaking research in colon cancer treatment strategies, specifically targeting stage II patients. The study utilizes innovative circulating tumor DNA analysis to guide adjuvant treatment decisions.

Stage II Colon Cancer
Circulating Tumor DNA Analysis
FOLFOX Therapy

This precision medicine approach aims to improve disease-free survival rates through personalized treatment selection.

Study on Using Oxaliplatin, Fluorouracil, and Folinic Acid for Treating Stage II Colon Cancer in Patients with Positive Circulating Tumor DNA

Recruiting

3 1 1 1
Investigated diseases:
- Colon cancer
Investigated drugs:
Study on Chemotherapy with Levoleucovorin, Capecitabine, and Folinic Acid for Patients Aged 70+ After Stage III Colon Cancer Surgery

Not recruiting

2 1 1 1
Investigated diseases:
- Colon cancer
Investigated drugs:
Title: Study of everolimus with hormone therapy in women with high-risk breast cancer (ER-positive, HER2-negative) who are disease-free after initial treatment

Not recruiting

3 1 1
Investigated diseases:
- Hormone receptor positive HER2 negative breast cancer
Investigated drugs:
- Everolimus
- Placebo

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Fluorouracil Folinic Acid Oxaliplatin Placebo Levoleucovorin Capecitabine Everolimus Show more

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

Colon cancer Hormone receptor positive HER2 negative breast cancer

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

Montélimar

Breast Cancer Research

Colorectal Oncology

Study on Using Oxaliplatin, Fluorouracil, and Folinic Acid for Treating Stage II Colon Cancer in Patients with Positive Circulating Tumor DNA

Study on Chemotherapy with Levoleucovorin, Capecitabine, and Folinic Acid for Patients Aged 70+ After Stage III Colon Cancer Surgery

Title: Study of everolimus with hormone therapy in women with high-risk breast cancer (ER-positive, HER2-negative) who are disease-free after initial treatment

Investigational Drugs in This Location

Medical Conditions Being Studied in This Location

We use cookies